Does Simvastatin have any box warnings listed?

Simvastatin does not carry any black box warnings as defined by the FDA. While the drug is associated with certain risks, particularly concerning interactions and side effects, it has not been designated with a black box warning. Black box warnings are the strongest warnings issued by the FDA and indicate that certain medications have significant risks that require careful consideration and monitoring.

In the case of Simvastatin, while there are known risks of muscle-related side effects, including myopathy and rhabdomyolysis, these are addressed in the prescribing information but do not fall under the category of a formal black box warning. This highlights the importance of healthcare providers being aware of these risks and actively monitoring patients, but it does not indicate a formal boxed warning exists. Thus, the correct response is that Simvastatin does not have any box warnings listed.